APA (7th ed.) Citation

Jang, H., Kim, K. Y., & Kim, D. S. (2018). Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease. Yonsei medical journal, 59(1), 113-118. https://doi.org/10.3349/ymj.2018.59.1.113

Chicago Style (17th ed.) Citation

Jang, Hyejin, Kyu Yeun Kim, and Dong Soo Kim. "Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease." Yonsei Medical Journal 59, no. 1 (2018): 113-118. https://doi.org/10.3349/ymj.2018.59.1.113.

MLA (9th ed.) Citation

Jang, Hyejin, et al. "Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease." Yonsei Medical Journal, vol. 59, no. 1, 2018, pp. 113-118, https://doi.org/10.3349/ymj.2018.59.1.113.